Cargando…
HIV inhibits endothelial reverse cholesterol transport through impacting subcellular Caveolin-1 trafficking
BACKGROUND: Human immunodeficiency virus (HIV) infection leads to decreased reverse cholesterol transport (RCT) in macrophages, and Nef mediated down-regulation and redistribution of ATP-binding cassette transporter A1 (ABCA1) are identified as key factors for this effect. This may partially explain...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501058/ https://www.ncbi.nlm.nih.gov/pubmed/26169283 http://dx.doi.org/10.1186/s12977-015-0188-y |
_version_ | 1782381000868757504 |
---|---|
author | Lin, Shanshan Nadeau, Peter E Mergia, Ayalew |
author_facet | Lin, Shanshan Nadeau, Peter E Mergia, Ayalew |
author_sort | Lin, Shanshan |
collection | PubMed |
description | BACKGROUND: Human immunodeficiency virus (HIV) infection leads to decreased reverse cholesterol transport (RCT) in macrophages, and Nef mediated down-regulation and redistribution of ATP-binding cassette transporter A1 (ABCA1) are identified as key factors for this effect. This may partially explain the increased risk of atherosclerosis in HIV infected individuals. Since endothelial dysfunction is key in the initial stages of atherosclerosis, we sought to determine whether RCT was affected in human aortic endothelial cells (HAECs). RESULTS: We found that apoA-I does not significantly stimulate cholesterol efflux in HAECs while cholesterol efflux to high-density lipoprotein (HDL) was dramatically reduced in HAECs co-cultured with HIV infected cells. Studies with wild type and Nef defective HIV revealed no significant differences suggesting that multiple factors are working perhaps in concert with Nef to affect cholesterol efflux to HDL from HAECs. Interestingly, treating HAECs with recombinant Nef showed similar effect in HDL mediated cholesterol efflux as observed in HAECs co-cultured with HIV infected cells. Using a detergent-free based subcellular fractionation approach, we demonstrated that exposure of HAECs to HIV infected cells or Nef alone disrupts caveolin 1 (Cav-1) subcellular trafficking upon HDL stimulation. Moreover, Nef significantly enhanced tyrosine 14 phosphorylation of Cav-1 which may have an impact on recycling of Cav-1 and caveolae. CONCLUSION: These results suggest that HIV interferes with cholesterol efflux by HDL in HAECs through the disruption of Cav-1s’ cellular distribution and that multiple factors are involved, possibly including Nef, for the inhibition of HDL mediated cholesterol efflux and alteration of cellular distribution of Cav-1. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12977-015-0188-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4501058 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45010582015-07-15 HIV inhibits endothelial reverse cholesterol transport through impacting subcellular Caveolin-1 trafficking Lin, Shanshan Nadeau, Peter E Mergia, Ayalew Retrovirology Research BACKGROUND: Human immunodeficiency virus (HIV) infection leads to decreased reverse cholesterol transport (RCT) in macrophages, and Nef mediated down-regulation and redistribution of ATP-binding cassette transporter A1 (ABCA1) are identified as key factors for this effect. This may partially explain the increased risk of atherosclerosis in HIV infected individuals. Since endothelial dysfunction is key in the initial stages of atherosclerosis, we sought to determine whether RCT was affected in human aortic endothelial cells (HAECs). RESULTS: We found that apoA-I does not significantly stimulate cholesterol efflux in HAECs while cholesterol efflux to high-density lipoprotein (HDL) was dramatically reduced in HAECs co-cultured with HIV infected cells. Studies with wild type and Nef defective HIV revealed no significant differences suggesting that multiple factors are working perhaps in concert with Nef to affect cholesterol efflux to HDL from HAECs. Interestingly, treating HAECs with recombinant Nef showed similar effect in HDL mediated cholesterol efflux as observed in HAECs co-cultured with HIV infected cells. Using a detergent-free based subcellular fractionation approach, we demonstrated that exposure of HAECs to HIV infected cells or Nef alone disrupts caveolin 1 (Cav-1) subcellular trafficking upon HDL stimulation. Moreover, Nef significantly enhanced tyrosine 14 phosphorylation of Cav-1 which may have an impact on recycling of Cav-1 and caveolae. CONCLUSION: These results suggest that HIV interferes with cholesterol efflux by HDL in HAECs through the disruption of Cav-1s’ cellular distribution and that multiple factors are involved, possibly including Nef, for the inhibition of HDL mediated cholesterol efflux and alteration of cellular distribution of Cav-1. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12977-015-0188-y) contains supplementary material, which is available to authorized users. BioMed Central 2015-07-15 /pmc/articles/PMC4501058/ /pubmed/26169283 http://dx.doi.org/10.1186/s12977-015-0188-y Text en © Lin et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Lin, Shanshan Nadeau, Peter E Mergia, Ayalew HIV inhibits endothelial reverse cholesterol transport through impacting subcellular Caveolin-1 trafficking |
title | HIV inhibits endothelial reverse cholesterol transport through impacting subcellular Caveolin-1 trafficking |
title_full | HIV inhibits endothelial reverse cholesterol transport through impacting subcellular Caveolin-1 trafficking |
title_fullStr | HIV inhibits endothelial reverse cholesterol transport through impacting subcellular Caveolin-1 trafficking |
title_full_unstemmed | HIV inhibits endothelial reverse cholesterol transport through impacting subcellular Caveolin-1 trafficking |
title_short | HIV inhibits endothelial reverse cholesterol transport through impacting subcellular Caveolin-1 trafficking |
title_sort | hiv inhibits endothelial reverse cholesterol transport through impacting subcellular caveolin-1 trafficking |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501058/ https://www.ncbi.nlm.nih.gov/pubmed/26169283 http://dx.doi.org/10.1186/s12977-015-0188-y |
work_keys_str_mv | AT linshanshan hivinhibitsendothelialreversecholesteroltransportthroughimpactingsubcellularcaveolin1trafficking AT nadeaupetere hivinhibitsendothelialreversecholesteroltransportthroughimpactingsubcellularcaveolin1trafficking AT mergiaayalew hivinhibitsendothelialreversecholesteroltransportthroughimpactingsubcellularcaveolin1trafficking |